Antibody–Drug Conjugates: Perspectives and Characterization
This instalment of “Perspectives in Modern HPLC” provides an overview of antibody–drug conjugates (ADCs) as a new class of biotherapeutics and describes their analytical characterization for quality assessment with examples from extensive applications libraries.
Perspectives and Characterization on Antibody–Drug Conjugates
Comprehensive characterization of ADCs requires increasingly powerful approaches consisting of small- and large-molecule techniques.